Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEACON: QVA149 vs Concurrent Indacaterol and Glycopyrronium in COPD
NCT01529632Phase 3Completed
- Sponsor
- Novartis
- Start
- May 2012
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of indacaterol + glycopyrronium in chronic obstructive pulmonary disease (COPD), sponsored by Novartis. Started May 2012; status: completed.
02
Drugs
indacaterol + glycopyrronium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01529632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01529632.